Moderna | MRNA - Interest Expense On Debt


Moderna reported $10.96B in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 1.06B 44.38M Sep/2026
Alnylam Pharmaceuticals USD -84.37M 166.42M Sep/2026
Amgen USD 653M 94.99B Sep/2026
Arrowhead Research USD 24.56M 716K Jun/2026
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 55.63M 7.67M Sep/2026
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 130M 70M Sep/2026
Gilead Sciences USD 269M 22M Sep/2026
GlaxoSmithKline GBP 219M 98M Sep/2026
Incyte USD 605K 23K Sep/2026
Ionis Pharmaceuticals USD 4M 14M Sep/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 10.96B 527M Jun/2026
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Puma Biotechnology USD 3.37M 11K Jun/2024
Qiagen NV USD 10.02M 1.03M Jun/2026
Regeneron Pharmaceuticals USD 11M 1.9M Jun/2026
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 21.51M 205K Jun/2026
Sartorius EUR 44.9M 4.6M Sep/2026
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 6.7M 2.73M Jun/2025
Ultragenyx Pharmaceutical USD 20M 2M Sep/2026
United Therapeutics USD 2.9M 0 Sep/2026
Vertex Pharmaceuticals USD 36M 32.7M Sep/2026
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025